Radiographic inhibition of structural damage sustained in patients with long-standing rheumatoid arthritis following 2 years of treatment with adalimumab (Humira®) plus methotrexate

被引：0
|
作者：
Keystone, EC
Kavanaugh, AF
Sharp, JT
Spencer-Green, G
Perez, JL
机构：
[1] Mt Sinai Hosp, Rebecca MacDonald Ctr Arthrit & Autoimmune Dis, Toronto, ON M5G 1X5, Canada
[2] UCSD, La Jolla, CA USA
[3] Univ Washington, Sch Med, Bainbridge Isl, WA USA
[4] Abbott Labs, Immunosci Dev Ctr, Parsippany, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [1] Radiographic inhibition of structural damage sustained in patients with long-standing rheumatoid arthritis following 3 years of treatment with adalimumab (HUMIRA®) plus methotrexate.
    Keystone, EC
    Kavanaugh, AF
    Sharp, JT
    Spencer-Green, GT
    Perez, JL
    Sasso, EH
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S189 - S189
  • [2] Three years of adalimumab (humira®) plus methotrexate therapy sustains radiographic inhibition of structural damage in patients with long-standing rheumatoid arthritis
    Keystone, EC
    Kavanaugh, AF
    Sharp, JT
    Spencer-Green, GT
    Perez, JL
    Sasso, EH
    [J]. RHEUMATOLOGY, 2005, 44 : I71 - I71
  • [3] Inhibition of radiographic disease progression in patients with long-standing rheumatoid arthritis following 3 years of treatment with adalimumab (HUMIRA®) plus methotrexate
    Keystone, EC
    Kavanaugh, AF
    Sharp, JT
    Spencer-Green, GT
    Perez, JL
    Sasso, EH
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 419 - 419
  • [4] Sustained radiographic inhibition with adalimumab (HUMIRA™) over 2 years in patients with long standing rheumatoid arthritis (RA).
    Keystone, EC
    Kavanaugh, A
    Sharp, JT
    Spencer-Green, GT
    Fischkoff, SA
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S315 - S315
  • [5] Inhibition of radiographic progression in patients with long-standing rheumatoid arthritis treated with adalimumab plus methotrexate for 5 years
    Keystone, E. C.
    Kavanaugh, A. F.
    Sharp, J. T.
    Patra, K.
    Perez, J. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 176 - 176
  • [6] Adalimumab (HUMIRA®) plus methotrexate induces sustained remission in both early and long-standing rheumatoid arthritis.
    Emery, P
    Schiff, MH
    Kalden, JR
    Spencer-Green, GT
    Segurado, OG
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S183 - S184
  • [7] The ARMADA trial:: Sustained efficacy and long-term safety of adalimumab (humira®) plus methotrexate over 3 years in patients with long-standing rheumatoid arthritis
    Weinblatt, ME
    Keystone, EC
    Furst, DE
    Kavanaugh, AF
    Spencer-Green, GT
    Mydler, T
    Segurado, OG
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 295 - 295
  • [8] ADALIMUMAB (HUMIRA®) INHIBITS RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH LONG-STANDING DISEASE: DATA AT TWO YEARS
    Keystone, E.
    Kavanaugh, A.
    Sharp, J.
    Spencer-Green, G.
    Segurado, O. G.
    [J]. RHEUMATOLOGY, 2004, 43 : 10 - 10
  • [9] Adalimumab (Humira®) plus methotrexate provides sustained improvements in physical function over 2 years of treatment in patients with rheumatoid arthritis
    Keystone, EC
    Kavanaugh, AF
    Perez, JL
    Spencer-Green, GT
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 278 - 278
  • [10] Sustained efficacy of adalimumab (HUMIRA™) plus methotrexate in rheumatoid arthritis (RA) patients.
    Schiff, MH
    Weisman, MH
    Furst, DE
    Kavanaugh, A
    Fischkoff, SA
    Spencer-Green, GT
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S314 - S315
12345